Abingworth as of Sept. 30, 2016
Portfolio Holdings for Abingworth
Abingworth holds 20 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sientra | 18.9 | $20M | 2.2M | 8.99 | |
| Proteon Therapeutics | 17.6 | $18M | 2.0M | 9.11 | |
| Paratek Pharmaceuticals | 16.2 | $17M | 1.3M | 13.00 | |
| Cempra | 8.9 | $9.3M | 384k | 24.19 | |
| Chiasma | 5.8 | $6.1M | 2.1M | 2.93 | |
| Dicerna Pharmaceuticals | 5.3 | $5.6M | 946k | 5.88 | |
| Novan | 3.9 | $4.0M | 200k | 20.16 | |
| Innocoll | 3.1 | $3.2M | 556k | 5.81 | |
| Lombard Med (EVARF) | 3.1 | $3.2M | 3.5M | 0.92 | |
| Cymabay Therapeutics | 3.0 | $3.1M | 1.6M | 1.94 | |
| Cellectis S A (CLLS) | 2.3 | $2.4M | 100k | 24.07 | |
| Dermira | 2.3 | $2.4M | 70k | 33.81 | |
| Senseonics Hldgs (SENS) | 1.9 | $2.0M | 517k | 3.87 | |
| Adaptimmune Therapeutics (ADAP) | 1.7 | $1.8M | 250k | 7.05 | |
| Anthera Pharmaceutcls | 1.5 | $1.5M | 512k | 2.99 | |
| Immune Design | 1.4 | $1.5M | 197k | 7.57 | |
| Aurinia Pharmaceuticals (AUPH) | 1.3 | $1.4M | 438k | 3.14 | |
| Regulus Therapeutics | 1.0 | $1.1M | 327k | 3.30 | |
| Histogenics Corp Cmn | 0.5 | $543k | 177k | 3.07 | |
| OncoGenex Pharmaceuticals | 0.2 | $194k | 396k | 0.49 |
